DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B

被引:22
|
作者
Chen, Yanmeng [1 ]
Shen, Bocun [1 ]
Zheng, Xiaochuan [1 ]
Long, Quanxin [1 ]
Xia, Jie [1 ]
Huang, Yao [1 ]
Cai, Xuefei [1 ]
Wang, Deqiang [1 ]
Chen, Juan [1 ]
Tang, Ni [1 ]
Huang, Ailong [1 ]
Hu, Yuan [1 ]
机构
[1] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Dept Infect Dis, Minist Educ,Inst Viral Hepatitis,Affiliated Hosp, 1 Yi Xue Yuan Rd, Chongqing 400016, Peoples R China
关键词
Hepatitis B virus; APOBEC3B; DHX9; interaction; attenuate; HEPATITIS-B-VIRUS; REPLICATION; RNA; MECHANISMS; INFECTION; MUTATION;
D O I
10.1080/22221751.2020.1725398
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatitis B virus (HBV) is a partially double-stranded DNA virus that replicates by reverse transcription. We previously demonstrated that the host restriction factor-APOBEC3B (A3B) inhibited HBV replication which was dependent on its deaminase activity during reverse transcription. However, the host factors involved in the process of regulating the anti-HBV function of A3B are less known. In this research, to obtain a comprehensive understanding of the interaction networks of A3B, we conducted coimmunoprecipitation and mass spectrometry to identify A3B-interacting proteins in the presence of HBV. By this approach, we determined that DExD/H-box helicase 9 (DHX9) suppressed the anti-HBV effect of A3B, and this suppression was dependent on their interaction. Although DHX9 did not affect the deamination activity of A3B in vitro assay or the viral DNA editing of A3B in HepG2-NTCP cells that support HBV infection, it inhibited the binding of A3B with pgRNA. These data suggest that DHX9 can interact with A3B and attenuate the anti-HBV efficacy of A3B.
引用
收藏
页码:366 / 377
页数:12
相关论文
共 50 条
  • [1] Role of APOBEC3B and APOBEC3A in oncogenesis
    Agarwal, Nikita
    Schutsky, Emily
    Kohli, Rahul
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [2] The role of APOBEC3B in chondrosarcoma
    Jin, Zhe
    Han, Ya-Xin
    Han, Xiao-Rui
    ONCOLOGY REPORTS, 2014, 32 (05) : 1867 - 1872
  • [3] The APOBEC3B transgenic mouse
    Choi, MiRan
    Lyle, L. Tiffany
    Song, Chisu
    Clare, Susan E.
    CANCER RESEARCH, 2018, 78 (04)
  • [4] APOBEC3B mutagenesis in cancer
    Kuong, Kawai J.
    Loeb, Lawrence A.
    NATURE GENETICS, 2013, 45 (09) : 964 - 965
  • [5] APOBEC3B mutagenesis in cancer
    Kawai J Kuong
    Lawrence A Loeb
    Nature Genetics, 2013, 45 : 964 - 965
  • [6] DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B
    Fu, Yang
    Ito, Fumiaki
    Zhang, Gewen
    Fernandez, Braulio
    Yang, Hanjing
    Chen, Xiaojiang S.
    BIOCHEMICAL JOURNAL, 2015, 471 : 25 - 35
  • [7] Determinants of Oligonucleotide Selectivity of APOBEC3B
    Wagner, Jeffrey R.
    Demir, Ozlem
    Carpenter, Michael A.
    Aihara, Hideki
    Harki, Daniel A.
    Harris, Reuben S.
    Amaro, Rommie E.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2019, 59 (05) : 2264 - 2273
  • [8] The mutagenic effects of APOBEC3A and APOBEC3B in urothelial carcinoma
    Sturdivant, Michael S.
    Truong, Andrew S.
    Zhou, Mi
    Damrauer, Jeffrey S.
    Kim, William Y.
    CANCER RESEARCH, 2023, 83 (07)
  • [9] The roles of APOBEC3B in gastric cancer
    Zhang, Jian
    Wei, Wei
    Jin, Hui-Cheng
    Ying, Rong-Chao
    Zhu, A-Kao
    Zhang, Fang-Jie
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 5089 - 5096
  • [10] APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression
    Yamazaki, Hiroyuki
    Shirakawa, Kotaro
    Matsumoto, Tadahiko
    Kazuma, Yasuhiro
    Matsui, Hiroyuki
    Horisawa, Yoshihito
    Stanford, Emani
    Sarca, Anamaria Daniela
    Shirakawa, Ryutaro
    Shindo, Keisuke
    Takaori-Kondo, Akifumi
    PLOS ONE, 2020, 15 (01):